- Home
- Formulary
IMF Edition 39, September 2026
Prescribing Information
New:
New in IMF, September 2026Safety Update:
Latest HPRA safety informationMedicines by Therapeutic Area
- 1.▌ Gastro-Intestinal Drugs
- 2.▌ Cardiovascular Drugs
-
2.1.Hypertension, Heart Failure
- 2.1.1.Angiotensin Converting Enzyme Inhibitors (ACEIs) and Combinations
- 2.1.2.Angiotensin II Antagonists (AIIAs, ARBs) and Combinations
- 2.1.3.Renin Inhibitors and Combinations
- 2.1.4.Alpha-Blockers
- 2.1.5.Centrally Acting Antihypertensives
- 2.1.6.Adrenergic Neurone Blockers
- 2.1.7.Beta-Blockers and Combinations
- 2.1.8.Cardiomyopathy
- 2.2.Calcium Channel Blockers, Nitrates, Other Antianginals
- 2.3.Lipid Regulating Drugs
- 2.4.Sympathomimetics
- 2.5.Antiarrhythmics
-
2.6.Anticoagulants, Antiplatelets, Antithrombotics
- 2.6.1.Heparin, Heparin Flush Solutions, Heparinoids
- 2.6.2.Synthetic Activated Factor X (Xa) Inhibitors
- 2.6.3.Direct Thrombin Inhibitors, Reversal Agents
- 2.6.4.Heparin Antagonists
- 2.6.5.Oral Anticoagulants
- 2.6.6.Antiplatelets Excluding Heparin
- 2.6.7.Non-Steroidal Antiplatelets, Aspirin
- 2.6.8.Antithrombotics, Enzymes and Proteins
- 2.7.Anti-Fibrinolytics, Haemostatics
- 2.8.Positive Inotropes
- 2.9.Diuretics
-
2.1.Hypertension, Heart Failure
- 3.▌ Central Nervous System Drugs
- 3.1.Antiepileptics
- 3.2.Antipsychotics, Antimanics
- 3.3.Antidepressants, Anxiolytics
- 3.4.Hypnotics
- 3.5.Parkinson's Disease, Restless Legs Syndrome
- 3.6.Multiple Sclerosis, Motor Neurone Disease, Other Nervous System Drugs
- 3.7.Dementia
- 3.8.Nausea and Vomiting, Vertigo, Motion Sickness
- 3.9.CNS Stimulants, Treatment of ADHD
- 4.▌ Analgesics, Anti-Inflammatories, Musculoskeletal Disorders
- 5.▌ Respiratory, Allergic Disorders
- 5.1.Asthma, COPD
- 5.2.Respiratory Corticosteroids and Combinations
- 5.3.Respiratory Leukotriene Receptor Antagonists
- 5.4.Other Respiratory System Products
- 5.5.Mucolytics
- 5.6.Cough Suppressants
- 5.7.Anti-Allergic Drugs, Allergic Emergencies
- 5.8.Cystic Fibrosis
- 5.9.Often Prescribed Non-Prescription (OTC) Products (Respiratory Disorders)
- 6.▌ Ear, Nose, Oropharynx
- 7.▌ Ophthalmology
- 8.▌ Obstetrics, Gynaecology, Urological Disorders
- 9.▌ Infectious Diseases
- 10.▌ Dermatology
- 11.▌ Endocrinology
- 12.▌ Immunology, Vaccines
- 13.▌ Oncology, Immunosuppression
- 14.▌ Anaesthesia
- 15.▌ Toxicology
- 16.▌ Haematology, Obesity, Metabolic Disorders
Additional Prescribing Support and Guidelines
- Antimicrobial Prescribing: Guidelines for Primary Care in Ireland (PDF)
- Immunisation: National Immunisation Schedule for Ireland
- Excipients: Non-active pharmaceutical ingredients
- Prescription Writing: Regulations, Requirements in Ireland (PDF)
- Preferred Medicines: Official Preferred Medicines for Ireland
- Terminology in Irish Healthcare: Reimbursement, Reference Price, Generic Substitution
- Disease Descriptions
- Herbal Supplements Information
- Safety: Adverse Reaction Report Form (HPRA) (PDF)